Health Equity & Access Weekly Roundup: June 5, 2026
β’ Federal initiatives have expanded a drug-price transparency tool and proposed a $50 per month access plan for eligible Medicare beneficiaries using GLP-1 medications. β’ The new pricing proposal is scheduled to take effect in July 2026, though debates continue regarding actual savings and remaining affordability gaps. β’ The weekly roundup also highlights critical health equity issues, including cancer trauma, abortion cost disparities, and the economic impact of food insecurity.
ajmc.com



